Institute of Medicine Elects 70 New Members, 10 Foreign Associates


Get Permission

Victor J. Dzau, MD

These leaders’ tremendous achievements have contributed significantly to advancing health and medicine.  The expertise and knowledge they bring to the IOM will encourage and enhance its success.

—Victor J. Dzau, MD

The  Institute of Medicine (IOM) has announced the names of 70 new members and 10 foreign associates during its 44th Annual Meeting held in October.  Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.   

“It is with great enthusiasm that we welcome our esteemed colleagues to the Institute of Medicine,” said IOM President Victor J. Dzau, MD.  “These leaders’ tremendous achievements have contributed significantly to advancing health and medicine.  The expertise and knowledge they bring to the IOM will encourage and enhance its success.”

New members are elected by current active members through a selective process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health.  A diversity of talent among IOM’s membership is assured by the Institute’s charter, which stipulates that at least one-quarter of the membership is selected from outside the health professions, for example, from such fields as the law, engineering, social sciences, and the humanities.  

The Institute of Medicine is unique in its structure as both an honorific membership organization and an advisory organization.  Established in 1970 by the National Academy of Sciences, IOM has become recognized as a national resource for independent, scientifically informed analysis and recommendations on health issues.  With their election, members make a commitment to volunteer their service on IOM committees, boards, and other activities.   

Newly elected members of the Institute of Medicine are:

  • Goncalo Rocha Abecasis, PhD, University of Michigan School of Public Health, Ann Arbor
  • Rafi Ahmed, PhD, PhD, Emory Vaccine Center; Emory University School of Medicine, Atlanta
  • Robert A. Aronowitz, MD, University of Pennsylvania, Philadelphia
  • Ben A. Barres, MD, PhD, Stanford University School of Medicine, Stanford
  • Jose Baselga, MD, PhD, Memorial Sloan Kettering Cancer Center, New York
  • Chris Beyrer, MD, MPH, Johns Hopkins Bloomberg School of Public Health, Baltimore
  • Walter F. Boron, MD, PhD, Myers/Scarpa Professor, and Chair, Department of Physiology and Biophysics, Case Western Reserve University, Cleveland
  • Carol R. Bradford, MD, Charles J. Krause, MD, University of Michigan Health System, Ann Arbor
  • Jeffrey Brenner, MD, Urban Health Institute at Cooper University Healthcare, and Camden Coalition of Healthcare Providers, Camden
  • Nancy J. Brown, MD, Vanderbilt University, Nashville
  • Lewis Clayton Cantley, PhD, Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College/New York-Presbyterian Hospital, New York
  • Arturo Casadevall, MD, PhD, Albert Einstein College of Medicine, New York
  • Elliot L. Chaikof, MD, PhD, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston
  • E. Antonio Chiocca, MD, PhD, FAANS, Brigham and Women’s/Faulkner Hospital; Dana-Farber Cancer Institute; and Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School, Boston
  • James J. Cimino, MD, NIH Clinical Center and National Library of Medicine, Bethesda
  • Patrick Conway, MD, MSc, Centers for Medicare & Medicaid Services, Baltimore
  • James E. Crowe Jr, MD, Vanderbilt University Medical Center, Nashville
  • Pamela B. Davis, MD, PhD, Case Western Reserve University, Cleveland
  • Linda C. Degutis, DrPH, MSN, Degutis Consulting, Atlanta
  • Joseph M. DeSimone, PhD, University of North Carolina and North Carolina State University, Chapel Hill
  • Jennifer E. DeVoe, MD, DPhil, Oregon Health and Science University, Portland
  • Daniel B. Drachman, MD, Johns Hopkins School of Medicine, Baltimore
  • James Economou, MD, PhD, University of California, Los Angeles
  • Eva L. Feldman, MD, PhD, A. Alfred Taubman Medical Research Institute, University of Michigan Health System, Ann Arbor
  • A. Mark Fendrick, MD, School of Public Health, University of Michigan, Ann Arbor
  • Stephanie Lida Ferguson, PhD, RN, FAAN, International Council of Nurses Leadership for Change Programme, Amherst, Virginia
  • Todd R. Golub, MD, Howard Hughes Medical Institute; Broad Institute of Harvard and MIT; Dana-Farber Cancer Institute, Cambridge
  • Eric P. Goosby, MD, UCSF School of Medicine, Global Health Sciences, San Francisco
  • Mark A. Hall, JD, Wake Forest University, Winston-Salem, North Carolina
  • Margaret Heitkemper, PhD, RN, FAAN, School of Nursing, University of Washington, Seattle
  • James O. Hill, PhD, Anschutz Health and Wellness Center, University of Colorado, Aurora
  • Bradley T. Hyman, MD, PhD, Harvard Medical School; MassGeneral Institute for Neurodegenerative Disease, Charlestown, Massachusetts
  • George Isham, MD, MS, Senior Adviser, HealthPartners, and Senior Fellow, HealthPartners Institute for Education & Research, Minneapolis
  • Julie A. Johnson, PharmD, College of Pharmacy, University of Florida, Gainesville
  • Paula A. Johnson, MD, MPH, Harvard Medical School; Harvard School of Public Health; Connors Center for Women’s Health and Gender Biology; Brigham and Women’s Hospital, Boston
  • Gerald F. Joyce, MD, PhD, Professor, Department of Chemistry, The Scripps Research Institute, La Jolla, California
  • Gerard Karsenty, MD, PhD, Columbia University, New York
  • Mitchell H. Katz, MD, director, department of health services, County of Los Angeles
  • Carol Keehan, DC, Catholic Health Association of the United States, Washington, DC
  • Sara Kenkare-Mitra, PhD, Hoffmann La-Roche, South San Francisco
  • Paul A. Khavari, MD, PhD, Stanford University, Stanford
  • Mary E. Klotman, MD, Duke University Medical Center, Durham
  • Brian K. Kobilka, MD, Stanford University School of Medicine, Stanford
  • Richard G. Kronick, PhD, U.S. Department of Health and Human Services, Rockville
  • Christian P. Larsen, MD, DPhil, Emory University, Atlanta
  • Steven H. Lipstein, MHA, BJC HealthCare, St. Louis
  • Catherine Lord, PhD, Center for Autism and the Developing Brain; Weill Cornell Medical College/New York-Presbyterian Hospital, White Plains, New York
  • Guillermina (Gigi) Lozano, PhD, The University of Texas MD Anderson Cancer Center, Houston
  • Edward Wilson Merrill, DSc, Massachusetts Institute of Technology, Belmont
  • Kelle Harbert Moley, MD, Washington University School of Medicine, St. Louis
  • Susan A. Murphy, PhD, University of Michigan, Ann Arbor
  • Harry T. Orr, PhD, University of Minnesota, Minneapolis
  • John Joseph O’Shea Jr., MD, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda
  • David R. Piwnica-Worms, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston
  • Kathleen Marie Potempa, PhD, RN, FAAN, University of Michigan School of Nursing, Ann Arbor
  • Meredith Rosenthal, PhD, Harvard School of Public Health, Boston
  • Bryan L. Roth, MD, PhD, University of North Carolina Medical School, Chapel Hill
  • W. Mark Saltzman, PhD, Yale University, New Haven
  • Randy Wayne Schekman, PhD, Howard Hughes Medical Institute; University of California, Berkeley
  • Martin Jose Sepulveda, MD, MPH, IBM Research, IBM Corp., Somers, New York
  • Michael N. Shadlen, MD, PhD, Howard Hughes Medical Institute; Zuckerman Mind Brain Behavior Institute, Kavli Institute for Brain Science, Columbia University, New York City
  • Joshua M. Sharfstein, MD, Maryland Department of Health and Mental Hygiene, Baltimore
  • Margaret A. Shipp, MD, Dana-Farber Cancer Institute, Boston
  • Bruce M. Spiegelman, PhD, Dana-Farber Cancer Institute, Harvard Medical School, Boston
  • Deepak Srivastava, MD, Gladstone Institute of Cardiovascular Disease; University of California, San Francisco
  • Robyn Stone, DrPH, Center for Applied Research, LeadingAge, Washington, DC
  • Joseph S. Takahashi, PhD,  Howard Hughes Medical Institute; University of Texas Southwestern Medical Center, Dallas
  • Dan Theodorescu, MD, PhD, University of Colorado Comprehensive Cancer Center, University of Colorado, Denver
  • Ronald David Vale, PhD, Howard Hughes Medical Institute; University of California, San Francisco
  • Gordana Vunjak-Novakovic, PhD, Columbia University, New York City

Newly elected foreign associates are:

  • Quarraisha Abdool Karim, PhD, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa
  • Pascale Cossart, PhD, Institut Pasteur, Paris
  • Christian J. Herold, MD, Vienna General Hospital, Medical University of Vienna, Vienna
  • Yang Ke, MS, Peking University; Peking University Health Science Center, Beijing
  • Jianan Li, MD, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • Denis Mukwege, MD, Panzi Hospital, Bukavu, Democratic Republic of the Congo  
  • Michael Vivian Sefton, PhD, University of Toronto, Toronto
  • Irma Thesleff, D.D.S., PhD, Institute of Biotechnology-University of Helsinki, Helsinki
  • Sheila Dinotshe Tlou, PhD, RN, Eastern and Southern Africa, UNAIDS, Johannesburg  
  • Charlotte Watts, PhD, London School of Hygiene and Tropical Medicine, London ■


Advertisement

Advertisement



Advertisement